TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS WITH SLOW INTRAVENOUS INJECTIONS OF THYMOPENTIN
- 1 April 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8433), 832-836
- https://doi.org/10.1016/s0140-6736(85)92205-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Thymopentin (TP-5) potency in vivo is enhanced by slow infusionInternational Journal of Peptide and Protein Research, 2009
- Phase variation in the modulation of the human immune responseImmunology Today, 1983
- Comparative efficacy of various routes of administration of thymopentin (TP‐5) with consideration of degradative mechanismsInternational Journal of Peptide and Protein Research, 1983
- Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 1982
- THYMOPOIETIN IN RHEUMATOID ARTHRITISRheumatology, 1982
- RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATIONThe Lancet, 1981
- Immunokinetics of a Single Dose of Thymopoietin PentapeptideJournal of Immunopharmacology, 1980
- SHORT IN VITRO HALF‐LIFE OF THYMOPOIETIN 32–36 PENTAPEPTIDE IN HUMAN PLASMAInternational Journal of Peptide and Protein Research, 1979
- MEASUREMENT OF PAINThe Lancet, 1974
- THYMIN: A THYMIC POLYPEPTIDE CAUSING THE NEUROMUSCULAR BLOCK OF MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1971